Future studies could address pathways of insulin secretion, chronic systemic inflammation or the gut microbiome (Mailing et al., 2019), all of which have been implicated as pathways to obesity and increased metabolic disease risk. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.